Article

Alcon repurchases one million shares

Alcon Inc. said it intends to purchase up to one million common shares by Dec. 31 from the public to cover employee equity compensation plans.

Hünenberg, Switzerland-Alcon Inc. said it intends to purchase up to one million common shares by Dec. 31 from the public to cover employee equity compensation plans. Nestlé SA and Novartis AG said they will not participate in the program.

Alcon has approximately 70 million shares that are publicly traded out of total outstanding shares of approximately 300 million, the company said in a prepared statement. Alcon has been engaged in share repurchases to cover employee equity compensation grants since going public in 2002.

Earlier this year, the board suspended share repurchases under all of its prior plans due to the anticipated share purchase and sale between Nestlé and Novartis.

Nestlé currently owns 52% of outstanding common shares and Novartis currently owns just under 25% as a result of that transaction, however, these ownership interest percentages are not expected to change as a result of the this share repurchase plan.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.